TD Asset Management’s AstraZeneca AZN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $304M | Sell |
1,621,109
-344,426
| -18% | -$64.8M | 0.26% | 78 |
|
|
2026
Q1 | $383M | Buy |
1,965,535
+1,409,114
| +253% | +$272M | 0.31% | 66 |
|
|
2025
Q4 | $102M | Buy |
556,421
+11,615
| +2% | +$2.04M | 0.08% | 191 |
|
|
2025
Q3 | $83.6M | Buy |
544,806
+90,636
| +20% | +$13.7M | 0.07% | 225 |
|
|
2025
Q2 | $63.5M | Sell |
454,170
-99,925
| -18% | -$14M | 0.05% | 268 |
|
|
2025
Q1 | $81.5M | Sell |
554,095
-81,368
| -13% | -$11.8M | 0.08% | 226 |
|
|
2024
Q4 | $83.3M | Sell |
635,463
-27,440
| -4% | -$3.84M | 0.07% | 227 |
|
|
2024
Q3 | $103M | Sell |
662,903
-90,311
| -12% | -$14.6M | 0.09% | 194 |
|
|
2024
Q2 | $117M | Sell |
753,214
-15,491
| -2% | -$2.33M | 0.11% | 171 |
|
|
2024
Q1 | $104M | Buy |
768,705
+60,938
| +9% | +$8.07M | 0.1% | 192 |
|
|
2023
Q4 | $95.3M | Sell |
707,767
-245,680
| -26% | -$31.9M | 0.09% | 193 |
|
|
2023
Q3 | $129M | Buy |
953,447
+260,752
| +38% | +$35.6M | 0.16% | 122 |
|
|
2023
Q2 | $99.2M | Sell |
692,695
-72,790
| -10% | -$10.7M | 0.11% | 145 |
|
|
2023
Q1 | $106M | Sell |
765,485
-43,488
| -5% | -$5.85M | 0.13% | 141 |
|
|
2022
Q4 | $110M | Sell |
808,973
-361,787
| -31% | -$45.4M | 0.14% | 134 |
|
|
2022
Q3 | $129M | Buy |
1,170,760
+147,819
| +14% | +$18.8M | 0.16% | 113 |
|
|
2022
Q2 | $135M | Buy |
1,022,941
+189,555
| +23% | +$24.9M | 0.16% | 117 |
|
|
2022
Q1 | $111M | Buy |
833,386
+8,956
| +1% | +$1.07M | 0.1% | 162 |
|
|
2021
Q4 | $96M | Buy |
824,430
+265,298
| +47% | +$31.2M | 0.08% | 198 |
|
|
2021
Q3 | $67.2M | Buy |
559,132
+64,086
| +13% | +$7.46M | 0.07% | 217 |
|
|
2021
Q2 | $56.7M | Buy |
495,046
+93,043
| +23% | +$10.2M | 0.06% | 264 |
|
|
2021
Q1 | $40M | Buy |
402,003
+112,609
| +39% | +$11.3M | 0.04% | 317 |
|
|
2020
Q4 | $28.9M | Buy |
289,394
+10,613
| +4% | +$1.12M | 0.04% | 353 |
|
|
2020
Q3 | $30.6M | Sell |
278,781
-12,465
| -4% | -$1.39M | 0.04% | 306 |
|
|
2020
Q2 | $30.8M | Buy |
291,246
+32,066
| +12% | +$3.31M | 0.04% | 277 |
|
|
2020
Q1 | $23.1M | Buy |
259,180
+9,809
| +4% | +$923K | 0.04% | 305 |
|
|
2019
Q4 | $24.9M | Sell |
249,371
-31,647
| -11% | -$2.98M | 0.04% | 346 |
|
|
2019
Q3 | $25.1M | Sell |
281,018
-71,289
| -20% | -$6.18M | 0.04% | 328 |
|
|
2019
Q2 | $29.1M | Sell |
352,307
-29,678
| -8% | -$2.33M | 0.04% | 310 |
|
|
2019
Q1 | $30.9M | Sell |
381,985
-45,757
| -11% | -$3.61M | 0.05% | 285 |
|
|
2018
Q4 | $32.5M | Sell |
427,742
-70,564
| -14% | -$5.51M | 0.06% | 259 |
|
|
2018
Q3 | $39.4M | Sell |
498,306
-33,825
| -6% | -$2.56M | 0.06% | 258 |
|
|
2018
Q2 | $37.4M | Buy |
532,131
+2,678
| +0.5% | +$193K | 0.06% | 259 |
|
|
2018
Q1 | $37M | Buy |
529,453
+2,448
| +0.5% | +$170K | 0.06% | 267 |
|
|
2017
Q4 | $36.6M | Buy |
527,005
+76,366
| +17% | +$5.15M | 0.05% | 268 |
|
|
2017
Q3 | $30.5M | Sell |
450,639
-2,203
| -0.5% | -$139K | 0.05% | 302 |
|
|
2017
Q2 | $30.9M | Buy |
452,842
+2,710
| +0.6% | +$177K | 0.05% | 288 |
|
|
2017
Q1 | $28M | Sell |
450,132
-2,827
| -0.6% | -$165K | 0.04% | 323 |
|
|
2016
Q4 | $24.8M | Buy |
452,959
+77,204
| +21% | +$4.38M | 0.04% | 324 |
|
|
2016
Q3 | $24.7M | Buy |
375,755
+72,546
| +24% | +$4.74M | 0.04% | 314 |
|
|
2016
Q2 | $18.3M | Buy |
303,209
+20,630
| +7% | +$1.2M | 0.03% | 366 |
|
|
2016
Q1 | $15.9M | Buy |
282,579
+22,753
| +9% | +$1.37M | 0.03% | 398 |
|
|
2015
Q4 | $17.6M | Buy |
259,826
+12,781
| +5% | +$838K | 0.04% | 358 |
|
|
2015
Q3 | $15.7M | Sell |
247,045
-113
| -0% | -$7.43K | 0.03% | 371 |
|
|
2015
Q2 | $15.7M | Buy |
247,158
+80,866
| +49% | +$5.54M | 0.03% | 388 |
|
|
2015
Q1 | $11.4M | Buy |
166,292
+65,858
| +66% | +$4.58M | 0.02% | 464 |
|
|
2014
Q4 | $7.07M | Buy |
100,434
+19,087
| +23% | +$1.37M | 0.01% | 582 |
|
|
2014
Q3 | $5.81M | Buy |
81,347
+20,831
| +34% | +$1.52M | 0.01% | 612 |
|
|
2014
Q2 | $4.5M | Sell |
60,516
-105,947
| -64% | -$7.66M | 0.01% | 680 |
|
|
2014
Q1 | $10.8M | Sell |
166,463
-8,199
| -5% | -$530K | 0.02% | 450 |
|
|
2013
Q4 | $10.4M | Buy |
174,662
+24,075
| +16% | +$1.31M | 0.02% | 437 |
|
|
2013
Q3 | $7.82M | Buy |
150,587
+141,163
| +1,498% | +$7.09M | 0.02% | 487 |
|
|
2013
Q2 | $446K | Buy |
+9,424
| New | +$480K | ﹤0.01% | 951 |
|
Other funds holding AZN
EPGL
VCM
VAM
VFT
TD Asset Management's AZN Position: Q2 2026 in Review
TD Asset Management reduced its AstraZeneca (AZN) stake by 18% in Q2 2026, selling an estimated $64.8M and leaving 1,621,109 shares worth $304M. The position accounts for 0.26% of the portfolio, ranked #78.
TD Asset Management first reported a position in AZN in Q2 2013 and has held it in 53 quarters since. The position peaked at $383M in Q1 2026. 1,253 funds tracked by Wall St. Rank hold AZN as of Q2 2026.
- TD Asset Management held 1,621,109 shares of AstraZeneca worth $304M as of Q2 2026.
- TD Asset Management sold 344,426 AstraZeneca shares in Q2 2026, an estimated $64.8M.
- AstraZeneca made up 0.26% of TD Asset Management's portfolio in Q2 2026, its #78 holding.
- TD Asset Management first reported a position in AstraZeneca in Q2 2013 and has held it in 53 quarters since.
- TD Asset Management's AstraZeneca position peaked at $383M in Q1 2026.
- 1,253 funds tracked by Wall St. Rank held AstraZeneca as of Q2 2026.
Based on TD Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.